IPIX — Innovation Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00- $2.18m
- $2.01m
Annual balance sheet for Innovation Pharmaceuticals, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.579 | 6.02 | 10.2 | 3.81 | 1.52 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.625 | 6.11 | 10.7 | 3.95 | 1.63 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.001 | 0 | — | — | — |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 4.05 | 9.25 | 14.3 | 10.4 | 7.52 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 7.3 | 7.37 | 6.54 | 4.81 | 5.02 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 8.18 | 7.79 | 6.79 | 5.65 | 5.48 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | -4.13 | 1.46 | 7.51 | 4.73 | 2.04 |
| Total Liabilities & Shareholders' Equity | 4.05 | 9.25 | 14.3 | 10.4 | 7.52 |
| Total Common Shares Outstanding |